✦ LIBER ✦

Meta-analysis of docetaxel-based doublet versus docetaxel alone as second-line treatment for advanced non-small-cell lung cancer

✍ Scribed by Wei-Xiang Qi; Zan Shen; Yang Yao

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Docetaxel and mitomycin as second-line t

✍ J. Feliu; G. Martín; J. Castro; A. Sundlov; A. Rodriguez-Jaráiz; E. Casado; M. L 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 209 KB

Clinical study of docetaxel-vinorelbine

✍ Jun Guo; Weiping Li; Degang Song; Zhehai Wang; Jie Liu; Changzheng Li; Zhen Chen 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 77 KB

Doublet regimen of cisplatin plus doceta

✍ Takashi Seto; Yoriko Takezako; Hiroko Nakamura; Kayo Takeda; Fumiko Inoue; Hiros 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 193 KB

A phase II study of S-1 monotherapy as s

✍ Yoshitaka Totani; Yuji Saito; Masamichi Hayashi; Toshihiko Tada; Yasuo Kohashi; 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 261 KB

The Role of Vandetanib in the Second-Lin

✍ Wei-Xiang Qi; Li-Na Tang; Ai-Na He; Zan Shen; Yang Yao 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 320 KB

Phase II study of weekly chemotherapy wi

✍ Kiyoshi Mori; Yukari Kamiyama; Tetsuro Kondo; Yasuhiko Kano; Tetsuro Kodama 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 330 KB